HCV INFECTION ( GENOTYPE 4) IN CKD PATIENTS

Clinical trials for HCV INFECTION ( GENOTYPE 4) IN CKD PATIENTS explained in plain language.

Never miss a new study

Get alerted when new HCV INFECTION ( GENOTYPE 4) IN CKD PATIENTS trials appear

Sign up with your email to follow new studies for HCV INFECTION ( GENOTYPE 4) IN CKD PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can tailored hepatitis c drugs cure infection in kidney patients?

Disease control Not yet recruiting

This clinical trial aims to find the safest and most effective hepatitis C treatment for people with chronic kidney disease (CKD). Researchers will compare two drug combinations based on how well the kidneys are working: one for patients with moderate kidney function and another …

Matched conditions: HCV INFECTION ( GENOTYPE 4) IN CKD PATIENTS

Phase: PHASE2, PHASE3 • Sponsor: Tanta University • Aim: Disease control

Last updated Aug 19, 2026 14:00 UTC

HCV INFECTION ( GENOTYPE 4) IN CKD PATIENTS

Get alerted when new HCV INFECTION ( GENOTYPE 4) IN CKD PATIENTS trials appear

Can tailored hepatitis c drugs cure infection in kidney patients?